Malignant fibrous histiocytoma (MFH), while rare, is the most prevalent soft tissue sarcoma (STS) found in extremities. Its prognosis hinges on factors such as tumor size, invasion depth, and differentiation degree. For MFH and all STSs, wide surgical resection is the gold standard treatment method. In this study, a 48-year-old woman, initially diagnosed with lipoma and with a mass excised from her right forearm, later exhibited recurring MFH masses in the same location. Superficial tissue ultrasonography identified malignant soft tissue tumors in the lesion area. Positron emission tomography was used to stage the tumor preoperatively, revealing fluorodeoxyglucose uptake in the repeating lesions. Right forearm magnetic resonance imaging confirmed the malignant lesions. Post imaging, the patient underwent wide surgical excision, eliminating the fascia. Regular follow-up revealed no recurrence or metastasis at 6 months and 1 year. Excisions frequently occur without radiological imaging, based only on a preliminary lipoma or sebaceous cyst diagnosis. However, excisions should follow radiological imaging, particularly when soft tissue tumors beneath the skin appear benign.
Objective: The Algan Hemostatic Agent (AHA) is a bioabsorbable, multi-herbal medical agent formulated to manage bleeding from surgical procedures and traumatic wounds. It is designed to be used when conventional hemostatic methods, such as compression or ligation, fail to adequately control capillary, venous, or arterial bleeding. This study aims to assess the hemostatic efficacy of AHA in two formulations—powder and liquid—using a rat tail transection model. Materials and Methods: This study included 24 Wistar Albino rats aged 10–12 weeks and weighing 250–280 g, which were randomly divided into three experimental groups (n = 8/group): 1) AHA powder, 2) AHA liquid-impregnated gauze-sponge, and 3) control (treated with a physiological saline-soaked sponge). A standardized tail transection procedure was performed on each rat to induce bleeding. Immediately following the transection, the designated treatment for each group was applied directly to the hemorrhage site. Bleeding cessation was assessed at 20-second intervals, and if bleeding persisted, the application was repeated for up to two additional attempts. Hemostasis was considered unsuccessful if bleeding continued after three consecutive applications of the assigned treatment. Results: Significantly shorter bleeding times were observed in both AHA-treated groups compared to the control group. None of the rats in the control group achieved hemostasis following three applications of the physiological saline-soaked sponge. In the AHA powder group, all 8 rats (100%) achieved hemostasis within the first 20 seconds of the initial application. In the AHA liquid-impregnated gauze-sponge group, 6 out of 8 rats (75%) achieved hemostasis after the first application, while the remaining 2 rats (25%) stopped bleeding after the second application. Statistical analysis revealed a significant difference between the control group and the two AHA-treated groups (p < 0.0001). Conclusions: These findings demonstrate the potential of AHA as a reliable hemostatic agent in both surgical settings and emergency situations where traditional methods are insufficient to control bleeding effectively. The rapid hemostasis achieved with AHA treatments suggests their utility in improving patient outcomes and minimizing blood loss in critical scenarios.
Introduction: The aim of this study was to evaluate the incidence of pulmonary embolism in relation to age, cancer, and other comorbidities; to assess clinical, laboratory, and radiological findings; and to examine the associated mortality rate. Materials and Method: Patients diagnosed with pulmonary embolism were included in this single-center retrospective study. The patients were divided into two age groups: < 60 and > 60 years. The incidence of pulmonary embolism; presence of deep vein thrombosis, cancer, surgical history; other comorbidities; mortality rate; prevalence of embolism; and C-reactive protein and D-dimer levels were evaluated according to age group and sex. Results: Of the 1,281 patients who underwent pulmonary computed tomography angiography for suspected pulmonary embolism, 235 were diagnosed with pulmonary embolism. Of these, 114 were female and 121 were male. The mean age was 62.3 ± 16.8 years. In the ≥60 age group, the proportion of females was significantly higher than that of males (p < 0.05). Cancer prevalence and C-reactive protein and D-dimer levels were also significantly higher in this group (p < 0.05). No statistically significant differences were observed between the age groups for the other evaluated parameters. Conclusion: The incidence of pulmonary embolism is higher in the elderly population, and the presence of additional conditions, particularly cancer, further increases the risk of pulmonary embolism. Careful monitoring of elderly patients for comorbidities, risk factors, and complications—such as pulmonary embolism—is crucial. Early diagnosis and timely treatment play vital roles in reducing mortality and significantly improving quality of life. Keywords: Pulmonary Embolism; Aged; Mortality; Neoplasms.
Calcifying fibrous tumor (CFT) is a rare benign lesion, mostly located in soft tissues, pleura and peritoneum. Differential diagnosis and total excision of the lesions are important. This is a case of a nineteen years old boy admitted to the emergency service with colic abdominal pain, guarding and rebound tenderness. Imaging modalities revealed nothing except minimal fluid at pelvic area. After 12 hours follow up, due to increament of rebound tenderness and guarding, the patient was taken to laparotomy. At exploration, 7x5x4 cm mass between small intestine mesentery and transverse colon mesentery, three 2x1x1 cm mass at antimesenteric part of terminal ileum, multiple white-gray calcified milimetric lesions at omentum and multiple lymphadenopathies (LAP) at ileum mesentery were determined. Omentum, all described lesions and 2 LAPs were excised. Treatment of CFT is total excision of lesions. No death or no metastasis are declared but few local recurrences are reported. Follow up is important.